PURPOSE
To evaluate the diagnostic contribution of diffusionweighted
magnetic resonance imaging (MRI) using
apparent diffusion coefficient (ADC) values to the
characterization of hepatic masses and differentiation
of benign and malignant lesions.
MATERIALS AND METHODS
The study included 30 patients that underwent upper
abdominal MRI examinations because of hepatic
masses that were found to be ≥1 cm in size with conventional
sequences, and were additionally evaluated
with diffusion-weighted MRI. Diffusion-weighted images
and ADC maps in the axial plane were obtained
using a 1.5 Tesla MRI device, single shot echo-planar
spin echo sequences on 3 axes (x, y, z), and diffusion
sensitive gradients with 2 different b values (b =
0 and b = 1000 s/mm2). Mean ADC measurements
were calculated among the 30 cases involving 41 hepatic
masses.
RESULTS
Of the 41 hepatic masses, 24 were benign and 17
were malignant. Benign lesions included 6 cysts, 14
hemangiomas, 2 abscesses, and 2 hydatid cysts. Malignant
masses included 8 metastases, 4 hepatocellular
carcinomas, 4 cholangiocellular carcinomas, and
1 gall bladder adenocarcinoma. The highest ADC
values were for cysts and hemangiomas. The mean
ADC value of benign lesions was 2.57 ± 0.26 x 10-3
mm2/s, whereas malignant lesions had a mean ADC
value of 0.86 ± 0.11 × 10-3 mm2/s. The mean ADC
value of benign lesions was significantly higher than
that of malignant lesions (P < 0.01).
CONCLUSION
Diffusion-weighted MRI with quantitative ADC measurements
can be useful in the differentiation of benign
and malignant liver lesions.